EurekAlert!

CRF announces TCT 2024 late-breaking clinical trials and science

NEW YORK – August 27, 2024 – The Cardiovascular Research Foundation ® (CRF ®) is pleased to announce the late-breaking clinical trials and science to be featured at TCT ® 2024. As the annual ...
Business Wire

TCT 2025 Late-Breaking Science: Quantitative Assessment of Non-Calcified Plaque Volume Drives Risk for Myocardial Infarction and Death

DENVER--(BUSINESS WIRE)--Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 Registry at the Transcatheter Cardiovascular ...
TCTMD

TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial

TCT 1154: The Relationship Between Race and Post-TAVR Bleeding Outcomes: Analysis from the Trans-Pacific TAVR (TP-TAVR) Registry Receive the the latest news, research, and presentations from major ...
TCTMD

TCT 525: Cutting Balloon versus Standard Balloon for Lesion Preparation of Drug-Coated Balloon Treatment in De-novo Coronary Artery Lesions: Primary Endpoint of the Randomized ...

TCT 671: From Transfer to Retention: In-Vivo OCT Insights into Crystalline Sirolimus Behavior After Drug-Coated Balloon Angioplasty in De Novo Lesions Receive the the latest news, research, and ...